Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism. (Q47722116)

5 February 2018

title

Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism. (English)

1 reference

5 February 2018

author

Johan Gabrielsson

4

1 reference

5 February 2018

author name string

von Bahr C

1

1 reference

5 February 2018

Steiner E

2

1 reference

5 February 2018

Koike Y

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

5 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

5 February 2018

volume

64

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

18-26

1 reference

5 February 2018

Partial metabolic clearances as determinants of the oral bioavailability of propranolol

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

First-pass metabolism of nortriptyline in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Influence of pentobarbital on metoprolol plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

The influence of enzyme induction on polymorphic sparteine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Phenobarbital induction of cytochrome P-450 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Pentobarbital elimination in patients with poor renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Enzyme induction in the cytochrome P-450 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Correlation between nortriptyline and debrisoquine hydroxylation in the human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Gas chromatographic determination of barbiturates by extractive alkylation and support coated open tubular column separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Dose-dependent enzyme induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Phenobarbital induces the 2-hydroxylation of desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Effect of pentobarbital on the disposition of alprenolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Influence of route of administration on drug availability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

The role of Barbie box sequences as cis-acting elements involved in the barbiturate-mediated induction of cytochromes P450BM-1 and P450BM-3 in Bacillus megaterium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Kinetic models of induction: I. Persistence of the inducing substance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

Multidose studies in the human metabolism of pentobarbitone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990018-2

10.1016/S0009-9236(98)90018-2

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9695715

1 reference

5 February 2018